Pharmacore secures funding to improve medication regimen reviews in long-term care Oobit Registers Legal Entity in Italy Amidst Global Expansion Push
Singapore, Singapore–(Newsfile Corp. – September 5, 2022) – Oobit Technologies Pte. Ltd or “the Company”,…
Dammam Valley/KSA to acquire the majority of Arcensus GmbH/Germany to accelerate the global implementation of Whole Genome Sequencing in genetic diagnostics and delivery of breakthrough technologies in genomic bioinformatics
ROSTOCK, Germany & DAMMAM, KSA, Sep 5, 2022 – (ACN Newswire) – Dammam Valley in…
LanzaTech NZ, Inc., to Participate in Upcoming Investor Conferences
CHICAGO–(BUSINESS WIRE)–LanzaTech NZ, Inc. (“LanzaTech”), an innovative Carbon Capture and Transformation (“CCT”) company that transforms…
Telent announces new Chairman
Warwick, U.K., September 5th 2022 – Telent Ltd, a leading UK technology and network services…
Biotimize Announces the Opening of a Fundraising Round to Build the First Biological CDMO in Brazil
PIRACICABA, Brazil, Sept. 05, 2022 (GLOBE NEWSWIRE) — Biotimize, a functional growth-stage biotechnology as a…
Apexigen Announces New Data from a Phase 2 Trial Evaluating its CD40 Antibody, Sotigalimab, in Combination with Neoadjuvant Chemoradiation in Patients with Resectable Esophageal and Gastroesophageal Junction Cancers at ESMO Congress 2022
SAN CARLOS, Calif., Sept. 05, 2022 (GLOBE NEWSWIRE) — Apexigen, Inc. (NASDAQ: APGN) a clinical-stage…
Synthetic Biologics Announces Presentation at ESMO Congress 2022 Describing Phase 1 Investigator-sponsored Study Evaluating VCN-01 in Combination with Durvalumab in Patients with Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and Neck
-Treatment with VCN-01 in combination with durvalumab demonstrated an acceptable safety profile and encouraging biological…
Reef’s Highly Anticipated Reef Card is Officially Available for Crypto Holders
â—Ź The Card is officially available for people in the UK and EEA and will…
Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in APAC
SYDNEY, Sep 5, 2022 – (ACN Newswire) – Novotech, the leading Asia Pacific biotech specialist…
Iskratel and S&T Slovenija merge to form S&T Iskratel
Kranj, Slovenia – 5 September 2022 – Customers of leading European ICT company Iskratel will…
Alvotech Reports Update on Initial AVT02 Biologics License Application
REYKJAVIK, Iceland, Sept. 05, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company…
Alvotech Reports Update on Initial AVT02 Biologics License Application
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar…
FreeYond F9, a Cost-Effective Smartphone, Announces That It Will Enter the Latin American Market Soon
Shenzhen, China–(Newsfile Corp. – September 5, 2022) – FreeYond F9, a smartphone from Shenzhen, will…
TOYOTA GAZOO Racing Heading Home to Fuji
TOKYO, Sep 5, 2022 – (JCN Newswire) – TOYOTA GAZOO Racing’s GR010 HYBRID Hypercar will…
DECOMAN from Hong Kong Utilizes Technologies to Go Global, Two More Markets in the APAC Region this year
SEOUL, SOUTH KOREA, Sep 5, 2022 – (ACN Newswire) – HK DECOMAN Technology Limited (“DECOMAN”)…
KBRA UK Releases Research – UK Consumer Crunch: Challenging Times Ahead
LONDON–(BUSINESS WIRE)–#KBRA–KBRA UK (KBRA) releases research that focuses on the UK consumer and the challenging…
M Mobility becomes Enreach
Enreach strengthens its rapid European growth strategy and presence in Denmark with the rebranding of…
Why EMQX Is Your Best Google Cloud IoT Core Alternative?
MORGAN HILL, CA, September 5, 2022 – Google made its decision to shut down Cloud…
Paysend Strengthens Executive Leadership Team with Wilhelm Rohde as Group CFO
LONDON – 05 SEPTEMBER 2022 – Paysend, the UK-based fintech, today announces the appointment of…
Press Release: Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children aged 6 to 11 years with moderate-to-severe asthma
 Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up…